van Krimpen C - Search Results

1

Cardiac remodeling in hypertension and following myocardial infarction: effects of arteriolar vasodilators.

Smits JF, Cleutjens JP, van Krimpen C, Schoemaker RG, Daemen MJ. Smits JF, et al. Among authors: van krimpen c. Basic Res Cardiol. 1991;86 Suppl 1:133-9. Basic Res Cardiol. 1991. PMID: 1827979 Review.

2

Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content.

Smits JF, van Krimpen C, Schoemaker RG, Cleutjens JP, Daemen MJ. Smits JF, et al. Among authors: van krimpen c. J Cardiovasc Pharmacol. 1992;20(5):772-8. J Cardiovasc Pharmacol. 1992. PMID: 1280740

3

DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril.

van Krimpen C, Smits JF, Cleutjens JP, Debets JJ, Schoemaker RG, Struyker Boudier HA, Bosman FT, Daemen MJ. van Krimpen C, et al. J Mol Cell Cardiol. 1991 Nov;23(11):1245-53. doi: 10.1016/0022-2828(91)90082-w. J Mol Cell Cardiol. 1991. PMID: 1803017

4

Angiotensin I converting enzyme inhibitors and cardiac remodeling.

van Krimpen C, Schoemaker RG, Cleutjens JP, Smits JF, Struyker-Boudier HA, Bosman FT, Daemen MJ. van Krimpen C, et al. Basic Res Cardiol. 1991;86 Suppl 1:149-55. Basic Res Cardiol. 1991. PMID: 1827981

5

Death from chemotherapy in gestational trophoblastic disease.

Hoogland HJ, Arends JW, Blijham GH, Braat SH, de Haan J, van Krimpen C. Hoogland HJ, et al. Among authors: van krimpen c. Eur J Obstet Gynecol Reprod Biol. 1988 Oct;29(2):167-72. doi: 10.1016/0028-2243(88)90144-x. Eur J Obstet Gynecol Reprod Biol. 1988. PMID: 3192036

6

Haemolytic disease of the newborn due to anti-K antibodies.

de Jonge N, Martens JE, Milani AL, Krijnen JL, van Krimpen C, Ponjee GA. de Jonge N, et al. Among authors: van krimpen c. Eur J Obstet Gynecol Reprod Biol. 1996 Jul;67(1):69-72. doi: 10.1016/0301-2115(96)02441-4. Eur J Obstet Gynecol Reprod Biol. 1996. PMID: 8789754

7

P53 and radiotherapy for oesophageal carcinoma: A comparison between 4 different antibodies.

Pomp J, Blom J, Zwinderman AH, Van Krimpen C. Pomp J, et al. Among authors: van krimpen c. Oncol Rep. 2000 Sep-Oct;7(5):1075-8. doi: 10.3892/or.7.5.1075. Oncol Rep. 2000. PMID: 10948341

8

Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome.

Pomp J, Davelaar J, Blom J, van Krimpen C, Zwinderman A, Quint W, Immerzeel J. Pomp J, et al. Among authors: van krimpen c. Radiother Oncol. 1998 Feb;46(2):179-84. doi: 10.1016/s0167-8140(97)00163-1. Radiother Oncol. 1998. PMID: 9510045 Clinical Trial.

9

Impact of Ovabloc intratubal polymer on the morphology of the fallopian tube.

van der Leij G, van Krimpen C. van der Leij G, et al. Among authors: van krimpen c. Int J Gynecol Pathol. 1995 Apr;14(2):167-73. doi: 10.1097/00004347-199504000-00011. Int J Gynecol Pathol. 1995. PMID: 8601529

10

E-cadherin expression in oesophageal carcinoma treated with high-dose radiotherapy; correlation with pretreatment parameters and treatment outcome.

Pomp J, Blom J, van Krimpen C, Zwinderman AH, Immerzeel JJ. Pomp J, et al. Among authors: van krimpen c. J Cancer Res Clin Oncol. 1999 Nov;125(11):641-5. doi: 10.1007/s004320050328. J Cancer Res Clin Oncol. 1999. PMID: 10541972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters